A Wall Street quant chief breaks down why a COVID-19 vaccine is not the silver bullet investors have been hoping for — and warns another stock-market meltdown is likely
Business Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
are being proven wrong. Two things broadly explain the speed of the snapback: the government's swift delivery of stimulus to Americans of all income levels, and the steady progress that pharmaceutical companies are making towards unleashing an effective
vaccine. That second catalyst is why investors are anticipating a permanent solution to the worst global health crisis since the 1918 Spanish flu. A vaccine would help rebuild economic activity that has been on ice since the first quarter, and turn around the fortunes of companies that have experienced sharp losses since then.
But it is possible that a vaccine will not immediately be the silver bullet that Wall Street expects. Andrew Lapthorne, the global head of quantitative research at Societe Generale, is taking this view with a word of caution on what it means for a stock market that has already overshot.
"With questions on the effectiveness and wide availability of vaccines remaining, as well as the potential impacts of the pandemic's damage to the economy, there may be more downside risk from markets overshooting," Lapthorne said in a recent note.
Read more:His concerns are both market- and vaccine-related.On the market front, he thinks investors are taking a premature victory lap that isout of line with historical recoveries, even after considering that stocks had plunged at record-breaking speed. On average, the S&P 500 recovered by 27% within a year after all 15 drawdowns of at least 30% since 1929. This time around, stocks leapt 45% in four months.
When it comes to the vaccine, Lapthorne has four specific concerns that throw cold water on the silver-bullet narrative. First, he flags that despite thenearly 200 vaccinesunder development, there is no guarantee that any will be effective on a massive scale. He also says that HIV still does not have a vaccine, although it's worth noting that there are treatments to keep people living with it healthy.
Second, there is no guarantee that the vaccine will be widely available. Lapthorne cited a survey conducted by Lazard, which showed that 73% of healthcare executives do not expect an effective vaccine to be accessible before the second half of 2021.Third, there will be people who decline to get vaccinated because they are anti-vaxxers or they doubt the safety of a COVID-19 vaccine. These folks may slow down the process of ensuring that herd immunity is achieved.
Fourth, it will take some time for people to unlearn their new pandemic habits and return to pre-COVID behavior even after a vaccine is available. Those habits include traveling by public transport, attending social events, and in-person gatherings — all of which help drive company revenues and overall economic activity.
Given these potential limitations of a vaccine, Lapthorne concludes that the stock market could be pricing in an economic recovery that will end up being less impressive than expected. "The long-term deleterious economic after-effects of pandemics could span multiple decades," Lapthorne said.
And unfortunately, history does not provide any clean parallel for what happens to the economy or the stock market after pandemics. The Spanish flu arrived just as World War I was ending, so it was a double whammy quite unlike what we're experiencing now.
But one thing is more certain to Lapthorne: Investors, in their forward-looking nature, have a habit of declaring victory before battles are over. And this rally could end up the history books as another example.Partner offer:Disclosure: TD Ameritrade is a partner of Insider, Inc.'s business development team, which is separate from its editorial department. We may receive a commission if you open an account.
NewsletterGet your daily markets analysis with our Markets newsletter. Sign up now.LoadingSomething is loading.Email address Read more: Business Insider »
Beirut reels from huge blast as death toll climbs to at least 135
Lebanese rescue teams pulled out bodies and hunted for missing in the wreckage of buildings on Wednesday as investigations blamed negligence for a massive warehouse explosion that sent a devastating blast wave across Beirut, killing at least 135.
HEPA and NBLX are my stock picks. Great buy. Good outlook.
'Underserved and underfunded': Inside California's county hit hardest by COVID-19As most of California begins a second shutdown over the coronavirus outbreak, no place has been hit as hard as Imperial County. I'm wondering how the homeless are faring with covid19..are they dropping like flies or..are they even being tested..? Anyone know? maggieNYT 0 tweets from CNN about the Epstein-Clinton scandal 0 tweets from MSNBC about the Epstein-Clinton scandal 0 tweets from nytimes about the Epstein-Clinton scandal 0 tweets from washingtonpost on the Epstein-Clinton scandal ENEMY OF THE PEOPLE maggieNYT There have been rules on appearance and behavior every step of the way: dress codes, table manners, respecting your elders, etc. Now, you don’t want to wear a mask because of freedom. It’s about life, dumbass.
Fauci optimistic COVID-19 vaccine will be widely availableOnce a coronavirus vaccine is approved as safe and effective, Americans should have widespread access within a reasonable time, Dr. Anthony Fauci assured lawmakers Friday. Appearing before a House panel investigating the nation&39;s response to the pandemic, Fauci expressed “cautious” optimism that
U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 VaccineThe U.S. agreed to spend $2.1 billion on a joint experimental Covid-19 vaccine from GlaxoSmithKline and Sanofi to supply the nation with an initial 100 million doses by iamsternlicht iamsternlicht Bullishness iamsternlicht Question is when? Please
Vaccine companies searching for 1-shot dose of COVID-19 vaccineVaccine companies searching for 1-shot dose of COVID-19 vaccine. COVID-19,कोरोना महामारी 6महीने में ऐसा बन्दर बन चुका है,जिसने पूरी दुनिया को नचा रखा है,सबने लॉकडाउन को ही इसका Vaccineमाना हैं।सरकार से प्रार्थना है,कृप्या अबतो COVID19 टीका सिघ्र बाजार में लाने की सिर्कत करे व देश की स्थिर सभी सनसाद्दनो को जनता हेतु पुन: संचालित करे।जय हिंद। Gotta make sure it kills the vessel first stick. Cant be to quick though or they know it was the needle. Maybe an hr?they may eat or drink and you can blame it on bad food or something in the water or somethin. Smart These are our heroes... The researchers.... brilliant scientists who are smart enough and motivated to finding a vaccine 4 covid-19🇺🇸🗽🙏
Fauci optimistic Covid-19 vaccine will be widely availableUnder direction from the White House, federal health authorities are carrying out a plan dubbed Operation Warp Speed to manufacture 300 million doses of a vaccine on a compressed timeline.
U.S. Drops $2.1 Billion on Experimental COVID-19 VaccineThe U.S. will pay “for development including clinical trials, manufacturing, scale-up and delivery of its vaccine'